Clinical trial
PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
NCT00966095
Study timeline
Study start (unknown)2009-12-01Date precision: month
Registry last updated2010-11-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
Sponsors & collaborators
Source MDxlead sponsor
Mapped research locations
New YorkNew York, United States2BostonMassachusetts, United States2DurhamNorth Carolina, United States2ChicagoIllinois, United States1DallasTexas, United States1BaltimoreMaryland, United States1San AntonioTexas, United States1SeattleWashington, United States1DenverColorado, United States1DetroitMichigan, United States1Ann ArborMichigan, United States1RochesterMinnesota, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00966095 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.